Purchase Order 75F40126P00137
Award Date 7/14/26
Potential Completion Date 7/14/27
Potential Value $77K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration awarded a $25,850 purchase order to Bruker Biospin Corp on August 11, 2022, for the procurement of cryogenic liquids required to support nuclear magnetic resonance (NMR) spectrometer installation and operations at the FDA's facility in Silver Spring, Maryland. The contract was structured as a firm fixed-price purchase order with an ultimate completion date of August 10, 2023, and did not utilize any small business set-aside designation. Cryogenic liquids,...
- The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp a firm fixed price purchase order for $119,796.45 to provide preventive maintenance for an Advance III HD700 nuclear magnetic resonance spectrometer cryoprobe and CryoPlatform system AVHD700X located in Silver Spring, Maryland. The award has a period of performance through February 2025 and includes two optional one-year extension periods. This award responds to a sources sought notification...
- The Food and Drug Administration awarded a $76,735.93 firm fixed-price purchase order to Bruker Biospin Corp for cryo-cooler servicing and preventative maintenance, with an ultimate completion date of August 11, 2023. The contract was awarded on August 10, 2022, without any set-aside designation, reflecting open competition. Work is to be performed at Bruker's facility in Billerica, Massachusetts. Bruker Biospin Corp, a subsidiary of Bruker Corporation, specializes in manufacturing advanced...
- The U.S. Food and Drug Administration awarded a $677,948.68 firm fixed price purchase order to Bruker Biospin Corp for a 400 MHz Nuclear Magnetic Resonance (NMR) spectrometer on September 29, 2021. The contract, which was completed by September 28, 2022, fulfills the FDA's Center for Drug Evaluation and Research requirement for high-resolution analytical equipment to characterize pharmaceutical ingredients, drug products, and excipients for stability and quality assessment in both liquid and...
- The Food and Drug Administration awarded a $120,290.40 firm fixed price purchase order to Bruker Biospin Corp for a Cryoprobe/Cryoplatform System Service Agreement. The contract, which was not set aside for small businesses, was awarded on July 11, 2023, with an ultimate completion date of September 24, 2026. Work will be performed at Bruker Biospin Corp's facility in Billerica, Massachusetts. Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, specializes in the design, manufacture, and...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments, in the amount of $238,161.00. The contract is for the delivery of a cryogenically-cooled 13C direct detect probe and 3 years of preventative maintenance for an existing Bruker nuclear magnetic resonance (NMR) spectrometry system. There was no set-aside designation for this award. The original...
- The Food and Drug Administration awarded a $214,185 firm fixed price purchase order to Bruker Biospin Corp for preventive maintenance and repair services on cryo-cooler components of a Bruker BioSpec 47/40 nuclear magnetic resonance imaging system located in Jefferson, Arkansas. The contract, awarded on May 10, 2023, extends through August 11, 2028, and does not utilize a set-aside designation. Bruker Biospin Corp, a subsidiary of Bruker Corporation headquartered in Billerica, Massachusetts,...
- The Department of Health and Human Services Food and Drug Administration awarded a $126,772 firm fixed price purchase order to Bruker Biospin Corp. to deliver a solid-state NMR probe. The place of performance is in Billerica, Massachusetts, with work expected to be completed by April 2024. Per the solicitation, the FDA requested quotes for a solid-state NMR probe to add to an existing 500-MHz instrument in order to expand its analytical capabilities. As the leading regulatory agency for ensuring...
- The U.S. Food and Drug Administration (FDA) awarded a $36,020 firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, for preventive maintenance and repair services for the cryo-cooler components of a Bruker Biospec 47/40 magnetic resonance imaging (MRI) unit located at the National Center for Toxicological Research (NCTR) in Jefferson, AR. The contract includes one scheduled on-site preventive maintenance service per year, unlimited on-site corrective...
- The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp. a $21,810 purchase order to provide helium fill maintenance services for a 600 MHz nuclear magnetic resonance spectrometer located in Billerica, Massachusetts. As the prime contractor, Bruker Biospin will perform the requested maintenance through December 2024 on the equipment, which is used to support the FDA's regulatory and research efforts. No subcontractors or set aside designations were...